Pan‐p63 or ∆Np63/p40 antibodies are useful marker of normal myoepithelium to identify benign lesions and discriminate invasive from in situ cancers in clinical material 4, 26, which complicates the analysis of p63 in tumour cells of primary breast cancers. This evidence concerns the gene TP63 and cancer.